Skip to content
healthcare.dev
Get a free key

Cetirizine hydrochloride

NDC 62207-764, Cetirizine hydrochloride, tablet, coated, from Granules India Ltd.

Product NDC
62207-764
Status
Listed
Labeler
Granules India Ltd
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA209274
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62207-764 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CETIRIZINE HYDROCHLORIDE10 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
62207-764-49622070764491000 TABLET, COATED in 1 BOTTLE (62207-764-49)
62207-764-556220707645514 TABLET, COATED in 1 BOTTLE (62207-764-55)
62207-764-736220707647313 BLISTER PACK in 1 CARTON (62207-764-73) / 10 TABLET, COATED in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 62207-764 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62207-764 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62207-764. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.